# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-186947
Filing Date
2026-04-28
Accepted
2026-04-28 16:06:43
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d938344dars.pdf | ARS | 1789857
| Complete submission text file | 0001193125-26-186947.txt |  | 2466619

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39269 | Film No.: 26907676
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)